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During September–October 2010, an unprecedented 
outbreak of Rift Valley fever was reported in the northern 
Sahelian region of Mauritania after exceptionally heavy 
rainfall. Camels probably played a central role in the local 
ampliﬁ   cation of the virus. We describe the main clinical 
signs (hemorrhagic fever, icterus, and nervous symptoms) 
observed during the outbreak.
F
rom late September through the beginning of October 
2010, unprecedented rainfall created large ponds in the 
oases of the Saharan region of Adrar, northern Mauritania 
(Figure 1). Such rains had not been observed for decades; 
the local residents refer to 1956 (locally known as the “year 
of the fever”) to describe similar events. This climatic event 
translated into unusual growth of vegetation, attracting 
shepherds and pastoralists from remote areas, including 
the southern and southeastern regions of the country. It 
also favored high densities of mosquitoes, mainly from 
the genus Culex and Anopheles (Cx. quinquefasciatus, An. 
pharoensis, An. protoriensis, Cx. poicilipes, An. gambiae, 
Aedes vexans, Cx. antenatus, An. ruﬁ  pes,  Mansonia 
uniformis, An. ziemani); some of these species were known 
to be competent vector species for major arboviruses.
A few weeks after these rains, severe outbreaks of 
malaria and Rift Valley fever (RVF) were reported in 
several oases (graret) of the Adrar region. Notably, the 
ﬁ  rst probable reportable case in livestock was in a sick 
dromedary camel and occurred during the last week of 
October 2010 in the Aoujeft area; the camel’s signs were 
similar to those of pasteurellosis. The herdsman slaughtered 
the animal before it died but delayed the cutting up of the 
meat because of the remote location. Subsequently, the 
uncooked meat was shared within the extended family, 
and within a few days, several people died with intestinal 
and hemorrhagic symptoms. Health authorities requested 
testing for several pathogens, including Crimean-Congo 
hemorrhagic fever and RVF; results were positive for RVF. 
Although these persons likely did not become infected 
through the consumption of meat (the fall in pH during 
meat maturation rapidly destroys the virus) (1), the virus 
was obviously circulating intensively in this area at that 
time.
Two weeks after the index case, additional cases in 
camels, abortion storms in small ruminants, and human 
deaths (hemorrhagic fever, icterus, and nervous symptoms) 
were reported on a massive scale. At the end of December 
2010, a total of 63 cases among humans, including 13 deaths, 
had been ofﬁ  cially reported, but the true number is probably 
much higher due to the remoteness of the affected area. Of 
14 initial blood samples from camels, 7 had positive test 
results by real-time reverse transcription PCR; the virus was 
isolated from 4 of those positive samples in the Laboratoire 
National d’Elevage et de Recherches Vétérinaires, Dakar, 
Senegal. The ﬁ  rst serologic results obtained by the central 
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Figure 1. Lefrass Oasis, 30 km north of Atar, one of the main 
outbreak foci of an outbreak of Rift Valley fever in camels, northern 
Mauritania. Inset shows the location of Atar and Aoujeft and the 
isohyets (average during 1965−2002; source: Food and Agricultural 
Organization of the United Nations, Land and Water Development 
Division).RVF Outbreak, Northern Mauritania
veterinary laboratory using a competitive ELISA (ID 
Screen Rift Valley Fever Competition Multispecies ELISA, 
ID-Vet, Montpellier, France) indicated an immunoglobulin 
(Ig) M/IgG prevalence of 33% in camels and 44% in small 
ruminants, respectively. IgM titers (2) were as high as 45% 
in Adrar and even reached 54% in the eastern Inchiri area 
2 weeks after the index case in the camel was observed 
(Table).
Serologic evidence of RVF in camels is frequently 
reported (3), yet the description of clinical signs is rare 
(4). Some authors mention subclinical or mild forms (5) or 
even the capacity to carry the virus without clinical signs 
(1). In contrast, in the past, widespread abortion waves 
in camels were observed during RVF outbreaks in Kenya 
and Egypt and were associated with positive serologic 
test results (6,7). Furthermore, camels are suspected of 
playing a major role in the spread of RVF from northern 
Sudan to southern Egypt in 1977 (8). It should be noted 
that RVF virus was previously isolated from blood 
samples from healthy, naturally infected camels in Egypt 
and Sudan (9,10) and that experimental infections with 
RVF virus have induced no clinical signs in nonpregnant 
dromedaries (3).
During this outbreak, 2 clinical forms were observed in 
camels: a hyperacute form, with sudden death in <24 hours; 
and an acute form with fever, ataxia, ballooning, edema at 
the base of the neck, audible expiratory wheeze and ventral 
positional dyspnea, blood-tinged nasal discharge, icterus, 
severe conjunctivitis with ocular discharge and blindness, 
hemorrhages of gums and tongue, foot lesions, nervous 
symptoms, and abortions (Figure 2). When hemorrhagic 
signs developed, death usually occurred within a few days.
The current understanding of the outbreak is that 
the exceptional rainfall during September–October 2010 
created highly favorable conditions for colonization 
and subsequent multiplication of competent vectors in 
these grarets. The virus was probably introduced rapidly 
through viremic animals transported by truck for grazing 
opportunities from various areas, including the south and 
southeastern regions of Mauritania where RVF is endemic 
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Table. Serologic data obtained from different regions, overall and per host species during Rift Valley Fever outbreak, northern
Mauritania, September–October 2010* 
Region 



















Adrar  179 83 (46)  81 (45)  168 79 (47)  77 (46)  11 4 (36)  4 (36) 
Brakna 17‡ 3 (18)  0 (0)  2 0 0 10 3 (30)  0
Gorgol  8 2 (25)  2 (25)  8 2 (25)  2 (25)  0 0 0
Inchiri 57 32 (56)  31 (54)  57 32 (56)  31 (54)  0 0 0
Nouakchott 239 65 (27)  1 (0)  27 1 (4)  1 (4)  212 64 (30)  0
Nouadibou  46 20 (43)  8 (17)  0 0 (0)  0 (0)  46 20 (43)  8 (17) 
Total 546 205 (37)  123 (23)  262 114 (43)  111 279 91 (33)  12 (4) 
*Ig, immunoglobulin.  
†IgM-positive samples within the IgM/IgG-positive population. 
‡Includes 5 cattle samples; all had negative test results. 
Figure 2. Observed clinical 
symptoms of Rift Valley 
fever in camels during ﬁ  eld 
investigation in the Adrar 
region, northern Mauritania. 
A) Conjunctivitis and ocular 
discharge, hemorrhages of the 
gums, and edema of the trough; 
B) hemorrhages of gums and 
tongue; C) foot lesions (cracks 
in the sole) with secondary 
myasis; D) edema at the base 
of the neck; E) dead camel with 
sign of abortion, convulsions, 
and arching of the neck.(11,12). To cope with this outbreak, veterinary and public 
health authorities took appropriate control measures, 
including restriction of livestock movement, re-allocation 
of locust control teams for mass insecticide spraying, 
and risk communication and public awareness campaigns 
aimed at the population at risk.
Conclusions
We report the unusual outbreak of RVF at a northern 
latitude and in an extremely arid region (although RVF 
has been reported in Egypt, where the Nile River helps 
spread the disease from the south). The high mortality 
rates and severe clinical signs observed among dromedary 
camels indicate that these animals played a major role in 
the epidemiology of this outbreak. The capacity of RVF-
infected Aedes spp. eggs to survive in such an environment 
also needs further assessment. Indeed, increasing capacities 
for long-distance transportation, associated with increasing 
frequencies of extreme and hard-to-predict weather events, 
may create a challenging scenario for exotic diseases in 
general, and RVF in particular, to spread.
During the course of the outbreak in Adrar, the price 
of livestock decreased by 40%, which created an attractive 
opportunity for traders who potentially could further 
disseminate the virus. Also, the possible role of oases as 
relay points has for some time been seen as a major risk for 
the introduction of RVF in the Maghreb, where eco-climatic 
and entomologic conditions are favorable for its emergence. 
These possible risk factors and the unusual appearance 
of RVF in an arid region call for further strengthening of 
surveillance and sanitary capacities and policies.
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